These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 25106556)
1. Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid. Meng F; Li Z; Yan J; Manjanatha M; Shelton S; Yarborough S; Chen T Mutagenesis; 2014 Sep; 29(5):357-65. PubMed ID: 25106556 [TBL] [Abstract][Full Text] [Related]
2. Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid. Li Z; Qin T; Wang K; Hackenberg M; Yan J; Gao Y; Yu LR; Shi L; Su Z; Chen T BMC Genomics; 2015 May; 16(1):365. PubMed ID: 25952319 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. Chen T; Guo L; Zhang L; Shi L; Fang H; Sun Y; Fuscoe JC; Mei N BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S20. PubMed ID: 17118142 [TBL] [Abstract][Full Text] [Related]
4. Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats. Chen L; Mei N; Yao L; Chen T Toxicol Lett; 2006 Sep; 165(3):250-6. PubMed ID: 16764999 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Chen T; Li Z; Yan J; Yang X; Salminen W Mutagenesis; 2012 Jan; 27(1):59-66. PubMed ID: 21976715 [TBL] [Abstract][Full Text] [Related]
6. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Tao L; Zeng Y; Wang J; Liu Z; Shen B; Ge J; Liu Y; Guo Y; Qiu J Mol Med Rep; 2015 Nov; 12(5):6533-46. PubMed ID: 26397152 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney. Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565 [TBL] [Abstract][Full Text] [Related]
8. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy. Debelle F; Nortier J; Arlt VM; De Prez E; Vienne A; Salmon I; Phillips DH; Deschodt-Lanckman M; Vanherweghem JL Arch Toxicol; 2003 Apr; 77(4):218-26. PubMed ID: 12698237 [TBL] [Abstract][Full Text] [Related]
9. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389 [TBL] [Abstract][Full Text] [Related]
10. Selective toxicity of aristolochic acids I and II. Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392 [TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis. Dong H; Suzuki N; Torres MC; Bonala RR; Johnson F; Grollman AP; Shibutani S Drug Metab Dispos; 2006 Jul; 34(7):1122-7. PubMed ID: 16611860 [TBL] [Abstract][Full Text] [Related]
12. Oral exposure to aristolochic acid I induces gastric histological lesions with non-specific renal injury in rat. Pu XY; Shen JY; Deng ZP; Zhang ZA Exp Toxicol Pathol; 2016 Jun; 68(6):315-20. PubMed ID: 27019954 [TBL] [Abstract][Full Text] [Related]
13. Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation. Malik AI; Williams A; Lemieux CL; White PA; Yauk CL Environ Mol Mutagen; 2012 Jan; 53(1):10-21. PubMed ID: 21964900 [TBL] [Abstract][Full Text] [Related]
14. Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction. Wang Y; Meng F; Arlt VM; Mei N; Chen T; Parsons BL Mutagenesis; 2011 Sep; 26(5):619-28. PubMed ID: 21642617 [TBL] [Abstract][Full Text] [Related]
15. Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats. Hu X; Shen J; Pu X; Zheng N; Deng Z; Zhang Z; Li H Toxicol Sci; 2017 Mar; 156(1):123-132. PubMed ID: 28115647 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the weak in vivo micronucleus response of a genotoxic carcinogen, aristolochic acids. Bhalli JA; Ding W; Shaddock JG; Pearce MG; Dobrovolsky VN; Heflich RH Mutat Res; 2013 May; 753(2):82-92. PubMed ID: 23500662 [TBL] [Abstract][Full Text] [Related]
17. Hepatic Premalignant Alterations Triggered by Human Nephrotoxin Aristolochic Acid I in Canines. Jin K; Su KK; Li T; Zhu XQ; Wang Q; Ge RS; Pan ZF; Wu BW; Ge LJ; Zhang YH; Wang YF; Shen GF; Zhu DY; Xiang CS; Li LJ; Lou YJ Cancer Prev Res (Phila); 2016 Apr; 9(4):324-34. PubMed ID: 26851235 [TBL] [Abstract][Full Text] [Related]
18. Plasma-specific microRNA response induced by acute exposure to aristolochic acid I in rats. Pu XY; Shen JY; Deng ZP; Zhang ZA Arch Toxicol; 2017 Mar; 91(3):1473-1483. PubMed ID: 27422293 [TBL] [Abstract][Full Text] [Related]
19. Aristolochic Acid in the Etiology of Renal Cell Carcinoma. Hoang ML; Chen CH; Chen PC; Roberts NJ; Dickman KG; Yun BH; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1600-1608. PubMed ID: 27555084 [TBL] [Abstract][Full Text] [Related]
20. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens. Koufaris C; Wright J; Currie RA; Gooderham NJ Toxicol Sci; 2012 Aug; 128(2):532-43. PubMed ID: 22584684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]